New Products &

New Indications

Recent Product Additions and New Indications
Oncology
Azacitidine for injection
Bavencio® (avelumab)
Imbruvica® (ibrutinib) - new indication
Keytruda® (pembrolizumab) - new indication
Lenvima® (lenvatinib)
Opdivo® (nivolumab) - new indication
Tecentriq® (atezolizumab) - new indication
Treanda® (bendamustine, HCl)
Zejula™ (niraparib)
Pharmaceuticals
Benlysta® (belimumab)
Ocrevus™ (ocrelizumab)
SalivaMAX™
Plasma Derivatives
Vonvendi® [von Willebrand factor (Recombinant)]


At ASD Healthcare, we continuously expand our product lines to ensure access to the products your patients need. We’re highlighting our newly added products here to make reviewing fast and easy. In addition, we're providing new product indications as they are approved by the FDA. To verify a product is appropriate for your facility to order, simply contact your sales representative. We’re always here to help.

To see the most up-to-date list of new products available from ASD Healthcare, simply check back each week!
 
Access additional
Product Resources